focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.175
Bid: 26.45
Ask: 27.90
Change: 0.975 (3.72%)
Spread: 1.45 (5.482%)
Open: 26.20
High: 0.00
Low: 0.00
Prev. Close: 26.20
REVB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Restoration of Trading

28 Jun 2023 07:00

RNS Number : 1190E
Revolution Beauty Group PLC
28 June 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For immediate release

28 June 2023

 

 

REVOLUTION BEAUTY GROUP PLC

("Revolution Beauty", the "Group" or the "Company")

 

Shares to be restored to trading on AIM today

 

Confirmation of grant of share options

 

Update on hostile shareholder action

 

Revolution Beauty Group plc (AIM: REVB), the multi-channel mass beauty innovator:

· announces that its shares are due to be restored to trading on AIM at 7.30 a.m. today;

· provides an update on the position with boohoo Group plc ("boohoo") following the Company's annual general meeting ("AGM") which was held yesterday, as previously announced; and

· confirms the grant of share options disclosed in the Company's annual report and accounts for the financial year to 28 February 2022, which were published on 26 May 2023 (the "FY22 Accounts").

The board of Revolution Beauty ("Board") remains focussed on value creation at this critical time for the Company, and continues to believe that boohoo's hostile actions are value-destructive, opportunistic and self-serving, as well as not being in the interests of the Company's shareholders as a whole. 

 

Shares to re-commence trading on AIM today

 

The Company is delighted to confirm that, in conjunction with its Nominated Adviser, it has requested that its shares be restored to trading on AIM at 7.30 a.m. today.

 

The Company's shares were suspended from trading on 1 September 2022, as the FY22 Accounts were not capable of publication at that time.

 

The Group faced a series of material and well-publicised issues, as summarised in prior announcements and in the Company's now-published FY22 Accounts. These historical issues culminated in an independent investigation into the actions of certain former directors and members of management and, as announced on 20 June 2023, in possible litigation against the Company's founder and former CEO, who retains a stake of approximately 15.8% in the Company.

 

Revolution Beauty's Board and management team, supported by their exceptional group of staff, have worked tirelessly for the last 10 months towards resolving the historical issues which have resulted in many detrimental outcomes for the Company's shareholders and other stakeholders.

Significant board and senior management changes were implemented in the wake of the independent investigation, and the directors and management team finally succeeded in completing the audit of the FY22 Accounts, as announced earlier this year. This was a significant step towards the restoration of the Company's shares to trading on AIM, and one that was achieved notwithstanding the historical issues uncovered during the independent investigation.

In addition to the publication of the FY22 Accounts, the management team have now also completed the following important steps that were required before the Company's shares were capable of being restored to trading on AIM:

- publication of the Group's interim results for the six-month period ended 31 August 2022 (released on 2 June 2023);

- as detailed in the interim results announcement on 2 June 2023, a review of the Group's Financial Position and Prospects Procedures (FPPP), to ensure that the Group's processes and procedures meet the standards required of an AIM company. This review is now complete, with all internal policy documentation (updated as appropriate) agreed and in place;

- a review of the Group's working capital has been completed. The directors commissioned a review of the Group's working capital to February 2025 and are satisfied the Group will have sufficient working capital during this period, and accordingly the Company's financial position has now been clarified. However, the Group draws the attention of shareholders to the material uncertainty regarding going concern disclosed in the FY22 Accounts and the FY23 interim results; and

- Rachel Maguire and Matthew Eatough were appointed yesterday as non-executive directors, and Derek Zissman, Bob Holt and Elizabeth Lake were re-appointed, to work alongside Jeremy Schwartz. The Company believes that its board is now well balanced and suitably experienced, with four non-executive directors and two executive directors, and is appropriate for a listed company of its size and stage of development.

Following the above, the Company and its Nominated Adviser, Zeus Capital, have requested that the shares of the Company be restored to trading on AIM, which is due to happen at 7.30 a.m. today.

Confirmation of grant of share options

As previously disclosed in the FY22 Accounts on 26 May 2023, the Board consider it important to retain and incentivise the Company's management team and to reward them for the hard work done and the trading performance improvement delivered over the past 10 months, especially in connection with the recently published accounts and other matters, including preparing for and achieving the Company's restoration to trading on AIM following the suspension of trading on 1 September 2022.

Given the imminent lifting of the suspension in trading, the Group's Remuneration Committee has now confirmed the grant of the share options contemplated by the FY22 Accounts on 26 May 2023 to Bob, Elizabeth and the other members of the Company's management team. The Company believes that these option awards will incentivise the management team to continue delivering growth in shareholder value.

5,684,210 nominal cost options were awarded to Bob Holt and 2,842,105 nominal cost options were awarded to Elizabeth Lake. In addition, 1,875,000 nominal cost options were granted to sixteen other members of the Company's management team. These nominal cost options represent, in aggregate, a total dilution of 3.4% to the Company's issued share capital.

The options awarded are fully vested, but the shares will be subject to a 12-month holding period.

The notification in the appendix to this announcement, made in accordance with the requirements of MAR, provides further detail on the awards made.

Update on the hostile shareholder

The Board reiterates its prior views regarding boohoo's attempted hostile takeover of the Company's board. The approach taken by boohoo towards Revolution Beauty is nothing short of value-destructive, opportunistic and self-serving. At a time when, thanks to management's tireless efforts, the Company's fortunes are significantly improved, with business back on track and restoration to trading on AIM occurring later today, boohoo is seeking to stage a board and management control coup without making a general offer, or paying a single penny, to independent shareholders of the Company.

Risks to shareholders in relation to the boohoo proposals and general meeting

The Company reminds shareholders of the potential risks attached to the boohoo proposals in relation to the Company's ability to retain its listing on AIM.

The fundamental changes to the Company's board proposed by boohoo could potentially lead to the Company not having an appropriate board of directors for a listed business. This could, if it is not able to be remedied to the satisfaction of the Company's Nominated Adviser (which would require, inter alia, the Nominated Adviser to be comfortable that boohoo does not have the ability to exercise undue influence and control over the Company) result in the Company's Nominated Adviser being unable to continue acting for the Company, and the Company's shares being suspended from trading on AIM again as a result. There is no guarantee that this could subsequently be remedied (either expeditiously or at all), meaning that shareholders could be left holding shares in an unlisted company with a board controlled by boohoo.

Shareholders should be aware that boohoo's actions, if they continue, are very likely to cause the accounts for the year ended 28 February 2023 ("FY23") to be significantly delayed, and reminds shareholders that if the accounts for FY23 are not published by the end of August 2023, the Company's shares would again be suspended from trading on AIM.

Absent the consent of the Group's lenders, a further suspension from AIM would also trigger a breach of the Group's banking facility.

All of these adverse consequences for the Company and its shareholders could be easily avoided.

Revolution Board continues to be open to dialogue

As previously announced, the Board continues to be prepared to engage with boohoo in good faith and in a constructive manner, to avoid the destruction of value for all shareholders.

The Company will make further announcements as required in due course.

In the meantime, shareholders are encouraged to support the current directors and the Company, but to take no other action.

Derek Zissman, Chair of Revolution Beauty, said:

"The Board is delighted that trading in the Company's shares will resume this morning. We believe that the restoration of liquidity is in the best interests of all of our shareholders."

For further information please contact:

Revolution Beauty Investor Relations

Bob Holt / Elizabeth Lake

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

Zeus (NOMAD): Nick Cowles /Jamie Peel /Jordan Warburton

Liberum: Clayton Bush / Edward Thomas / Miquela Bezuidenhoudt

 

Tel: +44 (0) 161 831 1512

Tel: +44 (0) 203 100 2222

Media enquiries:

Headland Consultancy

Matt Denham / Will Smith / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

The person responsible for arranging the release of this announcement on behalf of the Company is Elizabeth Lake, the Chief Financial Officer of the Company.

 

Appendix

PDMR disclosures

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bob Holt

 

2

Reason for the notification

a)

Position/status

Chief Executive Officer

 

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Revolution Beauty Group plc

b)

LEI

21380083TTJWXK677H17

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.01

 

ISIN: GB00BP7L1T61

b)

Nature of the transaction

Grant of options under the Revolution Beauty Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

£0.01

 

Volume(s)

5,684,210

 

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

25 June 2023

f)

Place of the transaction

Outside of trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Elizabeth Lake

 

2

Reason for the notification

a)

Position/status

Chief Financial Officer

 

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Revolution Beauty Group plc

b)

LEI

21380083TTJWXK677H17

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.01

 

ISIN: GB00BP7L1T61

b)

Nature of the transaction

Grant of options under the Revolution Beauty Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

£0.01

 

Volume(s)

2,842,105

 

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

25 June 2023

f)

Place of the transaction

Outside of trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RENNKOBKDBKBCAB
Date   Source Headline
30th Apr 20244:59 pmRNSTotal Voting Rights
29th Apr 20247:00 amRNSHolding(s) in Company
22nd Apr 20249:09 amRNSResponse to allegations by Chrysalis Investments
12th Apr 20244:43 pmRNSHolding(s) in Company
4th Apr 20247:01 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSHolding(s) in Company
3rd Apr 20249:40 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSTrading Update
11th Mar 20241:50 pmRNSTotal Voting Rights
20th Feb 20247:00 amRNSGrant of Share Options
19th Feb 20247:00 amRNSChange of Auditor
8th Feb 20247:00 amRNSCapital Markets Event and FY24 Trading Update
5th Feb 20247:00 amRNSAdam Minto Settlement Agreement
2nd Feb 20247:00 amRNSResponse to allegations by Chrysalis Investments
26th Jan 20247:00 amRNSBlock Admission Application
24th Jan 20247:00 amRNSNotice of Capital Markets Event
13th Dec 20237:00 amRNSDirectorate changes and settlement agreement
8th Dec 20237:00 amRNSChange of Adviser & Rule 17 Schedule Two(g) Update
27th Nov 20237:00 amRNSPress speculation
22nd Nov 20237:18 amRNSHolding(s) in Company
14th Nov 20231:29 pmRNSHolding(s) in Company
14th Nov 20231:25 pmRNSHolding(s) in Company
14th Nov 20231:23 pmRNSHolding(s) in Company
14th Nov 20237:00 amRNSInterim Results
9th Nov 20231:21 pmRNSNotice of Interim Results
31st Oct 20236:08 pmRNSHolding(s) in Company
31st Oct 20236:07 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSResults of AGM
19th Sep 20237:00 amRNSGrant of Share Options
13th Sep 20232:44 pmRNSHolding(s) in Company
5th Sep 20237:00 amRNSNotice of AGM and posting of Annual Report
4th Sep 20235:30 pmRNSHolding(s) in Company
4th Sep 20235:27 pmRNSHolding(s) in Company
31st Aug 20238:32 amRNSDirectorate Changes
31st Aug 20238:30 amRNSFINAL RESULTS FOR THE YEAR ENDED 28 FEBRUARY 2023
21st Aug 20237:00 amRNSNotice of Results
7th Aug 202312:45 pmRNSGeneral Meeting Indefinitely Adjourned
24th Jul 20234:22 pmRNSHolding(s) in Company
21st Jul 20234:57 pmRNSRegulatory Investigation
21st Jul 20231:43 pmRNSPDMR Dealing
21st Jul 202310:58 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSWithdrawal of GM requisition & Board Updates
18th Jul 20237:00 amRNSSettlement Agreement with boohoo
10th Jul 20234:49 pmRNSNotice of General Meeting
5th Jul 202310:37 amRNSChange of registered office address
4th Jul 20232:09 pmRNSDirector dealings
3rd Jul 20234:30 pmRNSDirector dealings
30th Jun 20237:00 amRNSResponse to boohoo

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.